Description
Salost DR 35 mg Tablet contains Risedronate Sodium, a bisphosphonate medication used for the treatment and prevention of osteoporosis and other bone diseases. The delayed-release formulation allows for weekly dosing with greater flexibility, often taken after breakfast, which enhances patient compliance compared to traditional fasting requirements.
Salost DR helps strengthen bones, reduce bone loss, and minimize the risk of fractures in conditions such as postmenopausal osteoporosis, osteoporosis in men, and glucocorticoid-induced bone loss.
 200ML.jpg)
 30 TAB.webp)
 200ML.webp)
60 ML 60 ML.webp)
 200 ML.jpeg)
 125ML.jpg)
 40 ML.png)
.webp)
 20ML.jpeg)
 250 ML.jpeg)
 125ML.webp)
 50ML.webp)
 15ML.webp)
 100ML.png)
 150GM.webp)
 200ML.webp)
.webp)
Change Language